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Abstract
Background: The endocannabinoid 2-arachidonoyl glycerol (2-AG) acts as a retrograde messenger and modulates synaptic
signaling e. g. in the hippocampus. 2-AG also exerts neuroprotective effects under pathological situations. To better
understand the mechanism beyond physiological signaling we used Organotypic Entorhino-Hippocampal Slice Cultures
(OHSC) and investigated the temporal regulation of 2-AG in different cell subsets during excitotoxic lesion and dendritic
lesion of long range projections in the enthorhinal cortex (EC), dentate gyrus (DG) and the cornu ammonis region 1 (CA1).
Results: 2-AG levels were elevated 24 h after excitotoxic lesion in CA1 and DG (but not EC) and 24 h after perforant pathway
transection (PPT) in the DG only. After PPT diacylglycerol lipase alpha (DAGL) protein, the synthesizing enzyme of 2-AG was
decreased when Dagl mRNA expression and 2-AG levels were enhanced. In contrast to DAGL, the 2-AG hydrolyzing enzyme
monoacylglycerol lipase (MAGL) showed no alterations in total protein and mRNA expression after PPT in OHSC. MAGL
immunoreaction underwent a redistribution after PPT and excitotoxic lesion since MAGL IR disappeared in astrocytes of
lesioned OHSC. DAGL and MAGL immunoreactions were not detectable in microglia at all investigated time points. Thus,
induction of the neuroprotective endocannabinoid 2-AG might be generally accomplished by down-regulation of MAGL in
astrocytes after neuronal lesions.
Conclusion: Increase in 2-AG levels during secondary neuronal damage reflects a general neuroprotective mechanism since
it occurred independently in both different lesion models. This intrinsic up-regulation of 2-AG is synergistically controlled by
DAGL and MAGL in neurons and astrocytes and thus represents a protective system for neurons that is involved in dendritic
reorganisation.
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Introduction
The endocannabinoid (eCB) system was shown to be involved in
processes of neurodegeneration. Increased concentrations of eCBs
such as 2-arachidonoylglycerol (2-AG) were found after different
brain injuries [1] and various cannabinoids protected against
ischemia, excitotoxicity or traumatic brain injury (TBI) [2,3,4,5].
Furthermore, the involvement of the eCB system in neurodegen-
erative diseases, like MS, Parkinson’s, Huntington’s and Alzhei-
mer’s disease is more and more unraveled [6,7,8,9].
Excitotoxic neuronal damage is reduced by 2-AG acting as a
retrograde neurotransmitter decreasing neuronal firing at gluta-
matergic synapses [10]. Affecting different cannabinoid receptors
and down-regulating the NFkB pathway 2-AG is involved in
analgesia and anti-inflammatory processes [4,5,11,12,13]. The
cannabinoid receptors type 1 (CB1) and type 2 (CB2) are the main
molecular targets of 2-AG [14,15]. CB1 is the most abundant G
protein-coupled receptor in the brain and resides at the pre-
synaptic side of neuronal synapses [16], whereas CB2 is mainly
situated on immunoregulatory cells, like microglial cells [17,18].
There are several reports in the literature indicating further not yet
cloned cannabinoid receptors that might be activated by 2-AG as
well [5,19]. 2-AG is synthesized on demand from membrane
glycerophospholipids by specific enzymes. Sn-1-diacylglycerol
lipase alpha (DAGL) is the primary biosynthetic enzyme of 2-
AG, found at the post-synapse of neurons [20]. Endocannabinoid
signaling is further controlled by enzymatic hydrolysis and the
principal 2-AG hydrolyzing enzyme is monoacylglycerol lipase
(MAGL) being ascribed for 85% of total 2-AG break down
[21,22].
However, so far little is known about the contribution of
different glial cell populations to 2-AG regulation and the time
course of its induction. Moreover, the precise regional control of 2-
AG in different brain areas still remains unknown. Therefore, we
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an in vitro model of Organotypic Hippocampal Slice Cultures
(OHSC) and investigated the temporal changes in 2-AG levels and
its main enzymes DAGL and MAGL after 1) long-range
projection damage as it occurs in stroke by transection of the
perforant pathway and 2) excitotoxic lesion as a central
mechanism of neuronal damage by application of NMDA. The
excitotoxic lesions were performed with low (10 mM) and high
(50 mM) NMDA doses to verify how sensitive the 2-AG machinery
responds to an excitotoxic insult.
The perforant pathway connects two evolutionary distinct brain
regions, namely the entothinal cortex (EC) and the outer
molecular layer of the dentate gyrus (DG) and its transection
allows the study of cellular and inflammatory responses not only at
the lesion site but also of anterograde projection areas
[23,24,25,26,27]. In the model of excitotoxicity the vulnerability
of different areas within the OHSC can be analyzed. The
regulation of 2-AG levels and the main synthesizing and
hydrolyzing enzymes were assessed up to 72 hours after perforant
pathway transection (PPT) and excitotoxicity in OHSC. More-
over, the respective cell types being responsible for 2-AG
metabolism, namely neurons, astrocytes or microglia were studied.
Materials and Methods
Ethics Statement
All animal experiments have been approved by the ethics
committees of the German federal state of Saxonia and were
performed in accordance with the Policy on Ethics and the Policy
on the Use of Animals in Neuroscience Research as approved by
the directive 2010/63/EU of the Council of the European Union
on the protection of animals used for scientific purposes. Animals
were maintained under a standard and a 12:12 hr light/dark
schedule and constant temperature with food and water available
ad libitum for the female rat. All efforts were made to minimize
suffering.
Organotypic Hippocampal Slice Cultures (OHSC)
8-day old Wistar rats were used to prepare OHSC. After
decapitation the brains were dissected under aseptic conditions
and transferred to 4uC minimal essential medium (MEM; Gibco
BRL Life Technologies, Eggenstein, Germany) containing 1% (v/
v) glutamine (Gibco) (Stoppini et al. 1991). With a sliding
vibratome (Leica VT 1200 S, Leica Microsystems AG, Wetzlar,
Germany) brains were horizontally cut in 350 mm-thick slices.
After dissection of the hippocampus the slices were immediately
placed on cell culture inserts (pore size 0.4 mm; Millipore,
Schwalbach/Ts., Germany) in 6-well culture dishes (Falcon, BD
Biosciences Discovery Labware, Bedford, MA) containing 1 ml
slice culture medium (50% (v/v) MEM, 25% (v/v) Hanks’
balanced salt solution (HBSS, Gibco), 25% (v/v) normal horse
serum (NHS, Gibco), 2% (v/v) glutamine, 1.2 mg/ml glucose
(Braun, Melsungen, Germany), 0.1 mg/ml streptomycin (Sigma-
Aldrich, Deisenhofen, Germany), 100 mg/ml penicillin (Sigma-
Aldrich), 0.8 mg/ml ascorbic acid (Sigma-Aldrich) and 1 mg/ml
insulin (Boehringer, Mannheim, Germany), pH 7.4) per well. The
slice cultures were kept at 35uC in a fully-humidified atmosphere
with 5% (v/v) CO2 for 6 days until lesion was set. The culture
medium was changed every other day.
Primary cell culture
Primary cell cultures of microglial cells and astrocytes were
isolated from cerebral cortices of neonatal Wistar rats (P1). The
meninges were removed and the cerebral cortices were dissociated
in Ca
2+/Mg
2+-free HBSS, containing trypsin (4 mg/ml, Boehrin-
ger) and DNAse (0.5 mg/ml, Worthington, Bedford, MA, USA).
Tissue culture flasks (75 cm
2, Falcon) were beforehand coated with
poly-L-lysine (Sigma-Aldrich) and contained cell culture media
(DMEM (Gibco), 4.5 g/L glucose (Gibco), 10% (v/v) fetal bovine
serum (FBS, Gibco), 1% (v/v) glutamine, 100 mg/ml penicillin and
100 mg/ml streptomycin) when cells were added and cultured until
further use. Microglial cells were separated from the astrocytic
monolayer and were subsequently plated into 24-well dishes
coated with poly-L-lysine with cell culture medium containing 2%
(v/v) FBS. Astrocyte cultures were also transferred one day prior
to experiments into 24-well dishes coated with poly-L-lysine.
Microglia and astrocytes were treated with 10 ng/ml lipopolysac-
charide (LPS) for 4 hours (h).
For primary cultures of hippocampal neurons a modified
method described by Brewer and colleagues was used [28]. Briefly,
Wistar rats P0 were used and brains were dissected quickly. The
meninges were removed and the brains were placed into an ice-
cold HBSS solution. Subsequently the hippocampi were dissected
and incubated in Neurobasal Medium (Gibco) containing BSA
(Sigma-Aldrich) and papain (1 mg/ml, Sigma-Aldrich) for 20 min
at 37uC. Neurons were isolated by dissociation and cultured onto
poly-L-lysine-coated coverslips in 24-well dishes in Neurobasal
medium supplemented with B-27 (Gibco), GlutaMAX (Gibco) and
penicillin/streptomycin at 37uC in a humidified atmosphere with
5% (v/v) CO2 for 2 weeks.
Excitotoxicity lesion
The OHSC were randomly divided into different treatment
groups and were treated according to the following treatment
protocol:
CTL: Unlesioned OHSC (n=5) were kept in culture medium
for 9 days in vitro (div) without any treatment and served as
controls.
JZL184: Unlesioned OHSC (n=6) were kept in culture
medium until 6 div. At 6 div the culture medium was
supplemented with 1 mM JZL 184 until 9 div.
NMDA: OHSC were kept in culture medium for 6 days,
lesioned with NMDA (50 mM; n=8, Sigma-Aldrich) for 4 hours
and maintained in culture medium until 9 div.
NMDA+JZL184: OHSC were lesioned at 6 div with NMDA
(50 mM; n=13, Sigma-Aldrich) for 4 h and kept in culture
medium supplemented with JZL 184 (1 mM) until 9 div.
OHSC treatment and 2-AG measurement. In an addi-
tional set of experiments OHSC were treated with low (10 mM) or
high (50 mM) NMDA concentrations for 4 h and were further
maintained in slice culture medium for 24 h or 72 h post lesion
(hpl). Controls were cultured with slice culture medium until 4 h,
24 h and 72 h, simultaneously with the NMDA treated OHSC. At
4 h, 24 h and 72 h samples were collected and processed for
immunohistochemistry or LC-MS/MS as described below.
Perforant Pathway Transection (PPT)
The PPT was mechanically set at 6 div by using a disposable
ophthalmic scalpel with a stainless steel blade (Feather, Osaka,
Japan). A binocular (Zeiss, Jena, Germany) was used to performed
PPT within OHSC. The cut was set through the perforant
pathway following the sulcus between the hippocampus and the
EC [29]. Dissection of the EC, the DG and the cornu ammonis 1
(CA1) region was done 0, 1, 6, 12, 24, 48 or 72 hpl. Similar
regions of three OHSC were pooled and shock frozen in liquid
nitrogen. The tissues were stored at 280uC and processed not
exceeding three days.
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Sample Extraction. Lipid extraction has been carried out as
previously described [30,31]. Briefly, 70 ml ice cold H2O was
added to the sample prior to homogenation by a mixer mill 400
(Retsch, Haan, Germany) for 90 sec at 25 Hz. Next, from the
homogenate 20 ml was collected to determine the beta-actin
content by Western Blot analysis (see below). The remaining 50 ml
of the homogenized tissue samples were then further processed
together with 25 ml internal standard (IS), 50 ml ethylacetate/n-
hexan and 50 mlH 2O. After 3 min at 10,000 rpm the samples
were centrifuged and the organic phase was collected, the
extraction procedure was repeated twice. Under nitrogen the
ethylacetate phases evaporated and the eCB were assimilated in
25 ml acetonitril in glass vials. 10 ml were injected into an LC-MS/
MS system (API, 5000, AB SCIEX, California, USA). Quality
standards were always extracted with the samples for accuracy.
Determination of endocannabinoid concentrations. 2-
AG and 1-AG were analyzed from the reconstituted samples.
Deuterated analytes 2-AG-d5, 1-AG-d5 were used as IS. Under
gradient conditions using a Luna HST C18 (2) column (100 mm
L62 mm ID, 2.5 mm particle size; Phenomenex, Aschaffenburg,
Germany) HPLC analysis was performed. An API 5000 triple
quadrupole mass spectrometer with a Turbo V source (Applied
Biosystems, Darmstadt, Germany) in the negative ion mode was
used to perform MS and MS/MS. For 2-AG the precursor-to-
product ion transitions m/z 377R303 was applied and m/z
382R303 for the deuterated 2-AG-d5 and 1-AG-d5 for the
multiple reaction monitoring (MRM) with a dwell time of 70 msec
respectively. The Analyst software (version 1.4; Applied Biosys-
tems) was used to evaluate concentrations of calibration standards,
quality controls and samples. ,15% over the range of calibration
were accepted as intra-day and inter-day variations in accuracy.
Semi-quantitative real time PCR (rtPCR)
The site specific and time dependent changes in enzymes,
DAGL and MAGL were analyzed by quantitative rtPCR. Tissue
was harvested and stored in RTLlater (Qiagen) at 280uC until
further use. Total RNA was extracted from the cells using TRIzol
reagent (Invitrogen) according to the manufacturer’s instructions.
RNA was measured and controlled for its purity by the A260/280
ratio. Total RNA was immediately reversely transcribed (Super-
script II, Invitrogen) with oligo(dT) primer cDNA. 50 ng of total
RNA was subjected to rtPCR using Platinum-SYBR GreenH
qPCR Supermix (Invitrogen). Oligonucleotide primers (Tab. S1)
were designed with the Primer3 software to flank intron sequences.
All primers were synthesized by MWG Biotech (Eversberg,
Germany) and diluted to 10 pmol/ml. Quantitative rtPCR was
performed by an CFX9 (Bio Rad laboratories, Mu ¨nchen,
Germany) using the following protocol: 3 min at 95uC and 40
cycles of 10 s at 95uC and 30 s at 61uC. A product melting curve
was recorded to confirm the presence of a single amplicon. The
correct amplicon size and identity were additionally confirmed by
agarose gel electrophoresis. Standard curves with serial dilutions of
cDNA were generated for each primer pair to assert linear
amplification. Threshold cycle (Ct) values were set within the
exponential phase of the PCR. After normalization to rodent
Figure 1. Intrinsic 2-AG regulation after neuronal damage - excitotoxic NMDA lesion and PPT. 2-AG levels in EC, DG and the CA1 region
normalized against ß-actin immunosignals. Control condition (CTR) of each time-point was set as 100% (black cycles). (A) 2-AG levels after application
of 10 mM and 50 mM NMDA. In the DG an increase in 2-AG was seen 24 hpl after 50 mM of NMDA. After 72 hpl 2-AG levels were elevated significantly
independent of the NMDA concentration. In the CA1 region increased 2-AG levels were measured 24 and 72 hpl after 10 mM and 50 mM NMDA
treatment (n=3, usig. for 10 mM NMDA, *sig. for 50 mM NMDA, up,0.05, uuu or ***p,0.001). (B) 2-AG levels after PPT. In EC 2-AG levels (gray circles)
did show a non significant alteration at 1 hpl in comparison to the respective CTR. In the DG, 2-AG was significantly increased 24 hpl (n=4, **p,0.01)
and in the CA1 region 2-AG levels did not differ significantly from CTR values (p.0.05).
doi:10.1371/journal.pone.0051208.g001
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PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e51208glyceraldehyde 3-phosphate dehydrogenase (GAPDH) primer, DCt
values were used to calculate the relative expression levels.
Western Blot analysis
Tissue was collected and immediately stored in lysis buffer at
280uC until further use. Protein was extracted in lysis buffer
containing 80 mM Tris, 70 mM SDS, 0,3 M Saccharose, 3 mM
sodium orthovanadate and 0.5 mM phenylmethylsulfonyl floride
(PMSF) at pH 7.4. Five mg protein were loaded onto a 7,5% or
12,5% (w/v) sodium dodecylsulfate–polyacrylamide gel. Proteins
were electrotransferred to nitrocellulose membranes and non-
specific protein-binding sites were blocked for 1 h with 5% (w/v)
milk (Carl Roth, Karlsruhe, Germany) or 5% (v/v) Roti-block
solution (Carl Roth, Karlsruhe, Germany) in TBST. Primary
antibodies were diluted in 5% (w/v) milk or 5% (v/v) Roti block in
TBST and membranes were incubated over-night. The following
primary antibodies were used: rabbit polyclonal antibody against
human DAGL (diluted 1:2000, Frontier Science, cat.-no DGLa-
Rb-Af380), rabbit polyclonal antibody against human MAGL
(diluted 1:1000; developed by K. Mackie) and mouse monoclonal
antibody directed against human beta-actin (diluted 1:40000; cat.-
No A1978, Sigma-Aldrich). Membranes were washed and the
secondary horse radish peroxidase-conjugated antibodies were
applied for 1 h (anti-rabbit, 1:1000; cat.-No PI 1000, Vektor
laboratories, Burlingame, CA; anti-mouse IgG, 1:4000; cat.-No
CP01, Millipore, Billerica, USA). The signal of bound antibody
was visualized by enhanced chemiluminescence (ECL detection
system, Millipore) with radiographic films (Kodak, Stuttgart,
Germany). ImageJ image analysis software (version 1.43, im-
agej.nih.gov/ij/download/) was used for semiquantification of the
immunoreactive bands. Preabsorption with the corresponding
blocking peptide was used to control the specificity of the MAGL
antibody (Fig. S1A).
Immunohistochemistry
For 4 h OHSC were fixed in 4% (w/v) PFA, washed and
incubated in 15% (w/v) sucrose before sectioning (14 mm) on a
cryostat 3050 S (Leica, Wetzlar, Germany). After blocking
unspecific bindings by normal goat serum (1:20 in PB saline
(PBS)/Triton) for 30 min primary antibodies were added for 16 h
in PBS/Triton containing 0.5% (w/v) bovine serum albumin:
DAGL (diluted 1:200, Frontier Science, cat.-no DGLa-Rb-Af380),
MAGL (diluted 1:200, Cayman Chemicals, cat no. 100035, Fig.
S1B), Vglut1 (diluted 1:1000, synaptic systems, cat no. 135311),
NeuN (diluted 1:200; cat.-No MAB377, Millipore), GFAP (diluted
1:200; cat. No 556330 BD Pharmingen) and biotinylated isolectin
B4 (IB4) (diluted 1:50; cat.-No FL-1201 Vector Laboratories).
Triple-immunofluorescence staining was done using the prima-
ry antibodies against DAGL or MAGL combined with IB4 and
either with NeuN or GFAP respectively. Sections were washed in
PBS prior to application of the secondary antibodies Alexa flour
dye 568 (1:500, goat-anti rabbit IgG) and Alexa fluor dye 633
(1:100, goat anti-mouse IgG; Invitrogen, Karlsruhe, Germany) for
1 h. The sections were coverslipped with Dako fluorescent
mounting medium (Dako) and visualized by a Zeiss LSM 510
Meta confocal laser scanning system equipped with helium neon
lasers (543 and 633 nm excitation lines) and an argon laser
(488 nm excitation line).
Propidium Iodide (PI) labeling and confocal
laserscanning microscopy
Two hours prior to fixation 5 mg/ml PI was added to the slice
culture medium. OHSC were then washed in PB and mounted
T
a
b
l
e
1
.
R
e
l
a
t
i
v
e
c
h
a
n
g
e
s
i
n
2
-
A
G
l
e
v
e
l
s
.
E
C
(
N
M
D
A
)
2
-
A
G
(
%
)
D
G
(
N
M
D
A
)
2
-
A
G
(
%
)
C
A
1
(
N
M
D
A
)
2
-
A
G
(
%
)
1
0
m
M
5
0
m
M
1
0
m
M
5
0
m
M
1
0
m
M
5
0
m
M
4
h
p
l
9
4
;
p
.
0
.
0
5
6
3
;
p
.
0
.
0
5
4
h
p
l
1
4
0
;
p
.
0
.
0
5
1
2
4
;
p
.
0
.
0
5
4
h
p
l
6
3
;
p
.
0
.
0
5
1
1
4
;
p
.
0
.
0
5
2
4
h
p
l
6
8
;
p
.
0
.
0
5
8
7
;
p
.
0
.
0
5
2
4
h
p
l
1
4
7
;
p
.
0
.
0
5
1
9
8
;
p
,
0
.
0
1
2
4
h
p
l
1
8
5
;
p
.
0
.
0
5
2
9
0
;
p
,
0
.
0
0
1
7
2
h
p
l
1
1
4
;
p
.
0
.
0
5
1
0
3
;
p
.
0
.
0
5
7
2
h
p
l
3
0
8
;
p
,
0
.
0
0
1
3
2
4
;
p
,
0
.
0
0
1
7
2
h
p
l
3
6
4
;
p
,
0
.
0
0
1
3
0
7
;
p
,
0
.
0
0
1
E
C
(
P
P
T
)
2
-
A
G
(
%
)
D
G
(
P
P
T
)
2
-
A
G
(
%
)
C
A
1
(
P
P
T
)
2
-
A
G
(
%
)
0
h
p
l
1
2
2
;
p
.
0
.
0
5
0
h
p
l
7
9
;
p
.
0
.
0
5
0
h
p
l
8
9
;
p
.
0
.
0
5
1
h
p
l
1
1
8
;
p
.
0
.
0
5
1
h
p
l
1
0
7
;
p
.
0
.
0
5
1
h
p
l
8
2
;
p
.
0
.
0
5
6
h
p
l
9
4
;
p
.
0
.
0
5
6
h
p
l
1
1
4
;
p
.
0
.
0
5
6
h
p
l
9
3
;
p
.
0
.
0
5
1
2
h
p
l
1
1
9
;
p
.
0
.
0
5
1
2
h
p
l
1
2
0
;
p
.
0
.
0
5
1
2
h
p
l
7
7
;
p
.
0
.
0
5
2
4
h
p
l
1
3
4
;
p
.
0
.
0
5
2
4
h
p
l
1
7
2
;
p
,
0
.
0
1
2
4
h
p
l
7
4
;
p
.
0
.
0
5
4
8
h
p
l
8
7
;
p
.
0
.
0
5
4
8
h
p
l
9
8
;
p
.
0
.
0
5
4
8
h
p
l
8
0
;
p
.
0
.
0
5
7
2
h
p
l
9
1
;
p
.
0
.
0
5
7
2
h
p
l
1
0
1
;
p
.
0
.
0
5
7
2
h
p
l
1
3
8
;
p
.
0
.
0
5
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
o
n
e
.
0
0
5
1
2
0
8
.
t
0
0
1
Intrinsic 2-AG Regulation after Neuronal Damage
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e51208with DAKO fluorescent mounting medium (DAKO Diagnostika
GmbH, Hamburg, Germany) and were analyzed with a Zeiss
confocal laser scanning microscope using the helium neon laser
543 (LSM 510, Zeiss, Gottingen, Germany). With 160-fold
magnification images were obtained using the Z-mode of the
confocal microscope, optically cutting the OHSC in 2 mm-thick
sections. Images were then converted into a binary image and
Image J software (version 1.43, imagej.nih.gov/ij/download/) was
used for PI-positive neuronal nuclei counting throughout the
granule cell layer (GCL) of the dentate gyrus. To correct for inter
experiment variances the different conditions were normalized to
the respective NMDA condition.
siRNA transfection
MAGL gene silencing was carried out using siRNA (target
sequence: 59-CAGCGTGCTGTCTCGGAACAA-39; sense
strand: 59-GCGUGCUGUCUCGGAACAATT-39; antisense
strand: 59-UUGUUCCGAGACAGCACGCTG-39; cat. no.:
SI03067736, Qiagen, Hilden, Germany) and GeneSilencer siRNA
transfection reagent (Genlantis-BioCat, Heidelberg, Germany) in a
6-well-culture plate. AllStars Negative Control siRNA (Qiagen)
was used as a negative control. Transfection was performed
according to manufacture’s instructions at 5 div for 24 h before
changing to native culture medium.
Figure 2. Enzymatic regulation of 2-AG after PPT. (A) Dagl and Magl mRNA regulation after PPT in the entorhinal cortex and the hippocampus
after PPT. Dagl was increased after 24 hpl of PPT in the DG. (n=3, *p ,0.05) (B) DAGL (open cycles) and MAGL (open cycles) protein regulation after
PPT in the entorhinal cortex and the hippocampus after PPT. DAGL was decreased after 24 hpl of PPT in the DG compared to the respective control
(closed cycles). (n=3, *p,0.05).
doi:10.1371/journal.pone.0051208.g002
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Data from at least three independent experiments were
expressed as mean values (+standard error of the mean (SEM)
and statistically analyzed using one way ANOVA followed by
Bonferroni posttests. Analysis was conducted with Graph Pad
Prism software 5 (GraphPad software, La Jolla, USA) and p,0.05
was considered significant. Gene regulation was statistically
evaluated by subjecting the DDCt values derived from each
preparation samples to one way ANOVA.
Results
2-AG levels are up-regulated after excitotoxic lesion and
PPT in areas of severe damage
Raw values of 3 pooled OHSC (EC, DG or CA1) contained
about 3–5 ng/ml 2-AG under control conditions. The obtained 2-
AG values were corrected for their ß-actin content and were then
given in percent values of the respective controls. The NMDA and
PPT data was expressed in relation to their time controls,
respectively (Fig. 1).
Excitotoxic lesion. Excitotoxic NMDA lesion and dendritic
denervation led to an intrinsic up-regulation of 2-AG levels in
specific brain regions, namely the DG and the CA1 region after
excitotoxic lesion with low and high NMDA doses (NMDA,
10 mM, 50 mM, Fig. 1A). In the EC 2-AG levels remained at
control levels after excitotoxic lesion with 10 mM and 50 mM
NMDA until 72 hpl (Fig. 1A). In the DG 10 mM NMDA
increased 2-AG levels 72 hpl (307.50%; p,0.001) but not at
4 hpl and 24 hpl (Fig. 1A). 50 mM NMDA increased 2-AG levels
at 24 hpl (197.60%) and 72 hpl (323.90%; p,0.001, Fig. 1A). 2-
AG levels of the CA1 region treated with 10 mM NMDA showed a
significant increase at 24 hpl (184.70%; p,0.05) and 72 hpl
(364.30%; p,0.001, Fig. 1A). After treatment with 50 mM NMDA
2-AG was enhanced at 24 hpl (290.20%; p,0.001) and 72 hpl
(306.70%; p,0.001, Fig. 1A). Single values of each group are
presented in Table 1.
Perforant Pathway Transection (PPT). After PPT no
significant changes of 2-AG levels were observed in the EC an
CA1 region (Fig. 1B). In the DG 24 hpl 2-AG levels were
significantly increased compared to controls (24 hpl, 172.20%;
p,0.01, Fig. 1B). Thereafter 2-AG levels declined to control levels
(Fig. 1B). Single values of each group are presented in Table 1.
Transcriptional dynamics of Dagl and Magl after PPT
Semi-quantitative real time PCR was used to investigate the
intrinsic regulation of (Dagl) and (Magl) enzymes of 2-AG in the
different regions over time.
In the EC and CA1 regions no changes of both mRNAs were
observed after PPT. Dagl and Magl expression were not
significantly different compared to the control OHSC (Fig. 2A).
In the DG Dagl expression was significantly enhanced 24 hours
after PPT (24 hpl, 175.40%; p,0.05, Fig. 2A) related to the
respective controls. Magl expression did not show significant
changes (Fig. 2A
Table 2. Relative changes in protein and mRNA levels after PPT.
EC
Protein (%) mRNA (%)
Group DAGL MAGL Group DAGL MAGL
0 h 101, p.0.05 105, p.0.05 CTR 100, p.0.05 100, p.0.05
6h 8 5 ,p .0.05 112, p.0.05 6 h 55, p.0.05 68, p.0.05
12 h 79, p.0.05 103, p.0.05 12 h 87, p.0.05 103, p.0.05
24 h 119, p.0.05 99, p.0.05 24 h 70, p.0.05 112, p.0.05
48 h 101, p.0.05 98, p.0.05 48 h 107, p.0.05 137, p.0.05
DG
Protein (%) mRNA (%)
Group DAGL MAGL Group DAGL MAGL
0 h 102, p.0.05 104, p.0.05 CTR 100, p.0.05 100, p.0.05
6 h 101, p.0.05 120, p.0.05 6 h 132, p.0.05 78, p.0.05
12 h 107, p.0.05 123, p.0.05 12 h 108, p.0.05 76, p.0.05
24 h 66, p,0.05 115, p.0.05 24 h 175, p,0.05 76, p.0.05
48 h 84, p.0.05 95, p.0.05 48 h 65, p.0.05 113, p.0.05
CA1
Protein (%) mRNA (%)
Group DAGL MAGL Group DAGL MAGL
0h 9 2 ,p .0.05 110, p.0.05 CTR 100, p.0.05 100, p.0.05
6 h 114, p.0.05 109, p.0.05 6 h 77, p.0.05 157, p.0.05
12 h 88, p.0.05 117, p.0.05 12 h 92, p.0.05 83, p.0.05
24 h 97, p.0.05 130, p.0.05 24 h 92, p.0.05 111, p.0.05
48 h 99, p.0.05 103, p.0.05 48 h 77, p.0.05 123, p.0.05
doi:10.1371/journal.pone.0051208.t002
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Western Blot analysis was used to investigate the intrinsic
regulation of DAGL and MAGL in different regions over time.
The respective time controls were set to 100%. No changes in
DAGL and MAGL were observed in the EC and CA1 regions
after PPT as compared to the time control OHSC (Fig. 2B). After
24 hpl DAGL protein was significantly decreased In the DG after
PPT (Fig. 2B, 24 hpl, 65.90%; p,0.05) related to the respective
controls. MAGL expression in the DG did not show significant
changes (Fig. 2B). Single values of each group are presented in
Table 2.
Cellular distribution of DAGL and MAGL in primary
neurons, microglia and astrocyte cultures
In isolated primary neuronal cultures DAGL immunoreaction
(IR) was observed within neuronal perikarya and processes. The
double staining of DAGL and VGLUT1 showed punctual
colocalizations (Fig. 3). MAGL IR was not observed to be co-
localized with VGLUT1 in primary neuronal culture.
In primary microglia cultures DAGL IR was located in the cell
body and became more intense after LPS treatment (Fig. 3).
DAGL IR was differentially distributed in astrocyte subtypes:
whereas fibrillary astrocytes showed a very weak DAGL IR after
LPS treatment only, protoplasmic astrocytes displayed a few
punctual immunoreactions spread throughout the cell body under
both, control and LPS treated conditions (Fig. 3). In IB4 positive
microglia, MAGL IR was found in the cytoplasm and at the cell
borders. Interestingly MAGL IR was very weak after LPS
treatment (Fig. 3). Fibrillary astrocytes displayed MAGL IR within
their cell bodies. In LPS treated cells, MAGL IR was seen in the
cell bodies and to a minor extent in their processes. The IR of
MAGL in protoplasmic astrocytes was very weak, no alteration
was observed between the control and the LPS treated condition.
Distribution of DAGL and MAGL in OHSC
Localizations of DAGL and MAGL IR were investigated by
immunohistochemical staining with NEUN, GFAP and IB4 in
sections obtained from OHSC at 1 hpl, 6 hpl, 12 hpl and 24 hpl.
Perforant pathway transaction. DAGL IR was found in
the cytoplasm of NeuN positive cells in control OHSC and in
OHSC after PPT. Co-localization of DAGL IR with GFAP IR in
astrocytes and IB4 positive microglial cells was hardly detectable in
control OHSC and no change was found in OHSC after PPT
until 12 hpl (not shown). After 24 hpl the DAGL IR remained in
the cytoplasm of neurons and a weak DAGL IR was seen in
astrocytes. Reorganization of DAGL IR was also observed 24 hpl,
the tight organization of the granular cell layer dispersed and
DAGL IR was found in the outer third but vanished in the inner
half of the granular layer (Fig. 4). In the hilus region of some PPT
lesioned OHSC enhanced DAGL IR was seen, however this
finding was not consistent in all PPT lesioned OHSC.
MAGL IR showed a punctual distribution in NeuN positive
cells (Fig. 4). GFAP positive astrocytes showed a strong co-
localization with the MAGL IR under control conditions.
Microglial cells displayed only weak or no MAGL IR in OHSC
(Fig. 4). Over time, microglial cells did not show a change of
MAGL IR in OHSC. At 24 hpl (PPT) MAGL IR was lower in
GFAP positive cells, no other changes in cellular distribution were
observed over time (Fig. 4).
Excitotoxic lesion. DAGL IR was found in the cytoplasm of
NeuN in OHSC after excitotoxic NMDA lesion and disappeared
24 hpl. After NMDA lesion DAGL IR was mainly found in
astrocytes and no longer in neuronal cytoplasm (Fig. 4).
MAGL IR was located in GFAP positive astrocytes under
control conditions and could not be seen after 24 hpl (NMDA) in
GFAP positive cells (Fig. 4).
Intrinsic up-regulation of 2-AG after MAGL inhibition by
JZL184 in OHSC
After JZL184 (1 mM) application for 4 h 2-AG levels increased
up to 35–45 ng/ml in OHSC and were significantly elevated in all
investigated regions (EC, 736%; p,0.01; DG, 688%; p,0.01,
CA1, 570%; p,0.05, Fig. 5A).
Inhibition of MAGL by JZL184 and Magl knock-down
using siRNA exerted neuroprotective effects after
excitotoxic lesion
Non-lesioned control OHSC exhibited a good neuronal
preservation with almost no PI positive neuronal nuclei. All
conditions were normalized against NMDA and given in percent
values (Fig. 5B). The application of 1 mM JZL184 did not led to
any significant alterations within the number of PI positive
neuronal nuclei as compared to CTR (JZL184, 0.24%, p.0.05).
Treatment of OHSC with 50 mM NMDA for 4 hours at 6 div
strongly increased the numbers of PI positive neuronal nuclei
(NMDA, 100%, p,0.001 vs. negative CTL) as compared to CTR.
Application of 1 mM JZL184 to NMDA-lesioned OHSC led to a
significant reduction of PI positive neuronal nuclei as compared to
Figure 3. Immunocytochemical analyses of DAGL and MAGL in
primary neuronal (left column), microglial (middle column) and
astrocyte (left columns) cell cultures. In neurons, DAGL was
distributed in the perikarya and in neuronal processes. VGLUT1 was co-
localized with DAGL suggesting a close surveillance of glutamate by
DAGL (arrows). MAGL was distributed in primary neuronal cultures but
displayed no overlap with VGLUT1 (arrow). Microglial cells were
labeled with DAGL in their cell bodies after LPS treatment. DAGL
expression was stronger than in controls (arrow). whereas, MAGL
expression in microglia was clearly visualized under control condition
around the nucleus and at the outer edges (arrows) of the cells the
labeling disappeared under LPS treatment (arrow). Astrocytes were
not found immunoreactive for DAGL in fibrillary astrocytes under
control condition, however DAGL was weakly induced after LPS
treatment. Protoplasmic astrocytes displayed a robust DAGL immuno-
reaction in controls and after LPS stimulation as visualized in droplets
throughout the cell body (arrows). MAGL was induced in both fibrillary
and protoplasmic astrocytes after LPS treatment (arrows). Bar=20 mm.
doi:10.1371/journal.pone.0051208.g003
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JZL184, 50.97%; p,0.05 vs. NMDA, Fig. 5B).
Non-lesioned OHSC treated with negRNA or siRNA
(negRNA, 0.28% siRNA, 0.28%) exhibited no different neuronal
preservation as compared to control OHSC with almost no PI
positive neuronal nuclei (CTL, 0.26%) in the DG. Treatment of
OHSC with 50 mM NMDA for 4 hours at 6 div strongly induced
the numbers of PI positive neuronal nuclei (NMDA, 100%,
p,0.001 vs. CTL) as compared to untreated CTL. Application of
negRNA to NMDA-lesioned OHSC showed no changes
(NMDA+negRNA, 121.83%; p.0.05 vs. NMDA), but the
application of siRNA led to a significant reduction of PI positive
neuronal nuclei compared to OHSC treated with NMDA alone
(NMDA+siRNA, 33.45%; p,0.05 vs. NMDA, Fig. 5C).
Discussion
Primary neurological insults are worsened by secondary
accumulation of harmful mediators leading to delayed tissue
damage and finally to persistent clinical and social disabilities for
patients [32]. Therefore, one aim in current neuroscience research
is the identification of biological mechanisms by which the
protective properties of intrinsic brain mechanisms can be
amplified with the final goal to develop clinical tools against
secondary neuronal damage. 2-AG is commonly accepted as a
beneficial mediator and an important member of the eCB system,
well known to protect neurons after neuronal insults mainly by
retrograde signaling finally leading to decreased neuronal excita-
tion [4,33,34,35]. Since the cell-type specific and temporal
regulation of 2-AG during secondary neuronal damage in the
brain was still fragmentary, we chose two different neuronal lesion
models to investigate whether the different areas within the
hippocampal formation would respond with a distinct time
dependent and area specific 2-AG up-regulation after low and
high concentrations of NMDA or PPT.
The EC showed no detectable changes in 2-AG levels after low
or high NMDA concentrations. The DG however showed
enhanced 2-AG levels 24 hours after the lesion with high NMDA
concentrations. Interestingly, low NMDA doses were sufficient to
enhance 2-AG significantly in the CA1 region. Being the region
with the highest density of NMDA receptors the CA1 region is the
most sensitive region to excitotoxic lesion [36]. Evidence exists that
the density of the 2-AG hydrolyzing enzyme, MAGL, is low on the
axon terminals of mossy cells and DAGL, the 2-AG synthesizing
enzyme, was shown to be abundant at the Schaffer collateral CA1
region of the hippocampal formation [37,38,39]. This strengthens
the relevance of 2-AG in the CA1 region during neuronal stress.
Enhanced 2-AG response to low NMDA concentrations might be
a possible mechanism to counteract the insult in the more
susceptible CA1 region. Stimulation of the Schaffer collateral
synapses shown by Stella et al. led also to an endogenous 2-AG
release in rat OHSC [40] and also short-term synaptic depression
was consistently enhanced by genetic inhibition of MAGL [41,42]
supporting the present data.
CNS pathologies like stroke involve lesion of long range
projections and a wide range of temporal cellular reorganization.
We focused on intrinsic 2-AG regulation after a model of long
range projection damage, the perforant pathway transaction in
OHSC. This model was described in detail recently [31] allowing
clear differentiation of anterograde (DG), retrograde (EC) and
more distant area (CA1) changes induced by axonal injury of long
range projections without leading to neuronal cell death. At the
direct axonal lesion site no changes of 2-AG were observed.
However, at the site of anterograde (dendritic) lesion a maximum
peak was seen 24 hours post lesion. We could clearly show that
axonal degeneration resulted in a moderate 2-AG increase at the
Figure 4. DAGLa and MAGL immunoreaction in OHSC 24 h after PPT. Images show the molecular layer (ml), the granular cell layer (gcl) and
part of the hilus (hi) region. The enzymes DAGL and MAGL are given in green, GFAP in red and IB4 positive microglial cells are displayed in blue. The
asterisks indicate NeuN co-localized DAGL and MAGL staining in the gcl (NeuN data not shown). DAGL was co-localized with GFAP positive cells only
after PPT and NMDA excitotoxic lesion but not in control OHSC (big arrows). IB4 positive microglial cells were not DAGL immunoreactive under
control conditions or after neuronal damage (small arrows). After PPT the DAGL was seen in the outer half of the gcl whereas the inner half of the
granular cell layer was not labeled (24 hpl, asterisk). GFAP positive cells expressed a strong co-localization with the MAGL protein in control OHSC
that disappeared 24 h after PPT and in NMDA lesioned OHSC (big arrows). A weak MAGL immunoreaction was found in vesicular structures in
microglial cells presumably representing phagocytosis bodies in their cytoplasms (small arrows). (Bar=50 mm).
doi:10.1371/journal.pone.0051208.g004
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CA1 region, postulating the involvement of 2-AG regulation in
dendtitic re-organisation.
To assess the involvement of 2-AG in dendritic reorganization
we investigated the regulation of the main synthesizing (DAGL)
and hydrolyzing (MAGL) enzymes of 2-AG. Dagl mRNA
remained unchanged after PPT in the EC and was increased
24 hpl in the DG, whereas Magl mRNA remained at control
levels. DAGL
2/2 mice show reduced 2-AG levels and it was found
that DAGL is functionally involved in neurogenesis [43,44].
Increased Dagl mRNA levels might therefore explain the enhanced
2-AG levels of the anterograde lesion site as suggested by a
previous spinal cord study [45]. In our study the investigation of
DAGL protein levels over time surprisingly revealed a decreased
DAGL protein expression 24 hours after PPT.
A possible explanation for enhanced Dagl mRNA expression
and increased 2-AG levels together with decreased DAGL protein
expression might be ubiquitination of DAGL as reported in
development and axonal growth [20,49]. Ubiquitination is
common among proteins involved in signaling events, where
rapid regulation is important,. Very recently two enzymes
(Phospholipase D1, Cyclooxygenase-1 (COX-1)) involved in
arachidonic acid regulation were shown to be ubiquitinated
[46,47]. Intra-cellular calcium concentration was responsible in
human embryonic kidney 293 cells for ubiquitinated COX-1
degradation [46]. The fast turnover of proteins via the ubiquitin–
proteasome system is a fundamental mechanism for cells to control
signal transduction, cell cycle regulation and transcription [48,49].
Another hypothesis might be the reflectory increase in Dagl mRNA
in response to decreased DAGL protein levels. To evaluate this
hypothesis additional time points of investigation between 12 hpl
and 24 hpl will be needed.
To clarify the regulation of DAGL and MAGL more precisely,
we investigated their cellular distribution in neurons, microglia
and astrocytes under control and LPS- stimulated conditions in
OHSC as well as in primary cell cultures. DAGL was strongly
found in neurons and was only weakly present in astrocytes of
control OHSC. In primary neuronal cultures we found DAGL
colocalized with Vglut1 at pre-synapses confirming previous
reports in cerebellar, hippocampal and striatal neurons showing
DAGL at the dendritic spines in the CA1 subfield, linked to the
intracellular surface of the plasma membrane [38,39,50,51]. In the
present study, we found a re-organization of DAGL immunore-
action especially after PPT towards the area of dendritic
reorganization. Interestingly, the DAGL immunoreaction in-
creased in astrocytes after both, PPT and excitotoxicity. Reactive
GFAP positive astrocytes have been found to produce 2-AG and
express DAGL in a valuable amount [52] either in vitro or in vivo
in the epicenter of spinal cord injury [45]. In addition, our findings
are in line with a previous descriptions of intense 2-AG production
after stimulating isolated astrocytes with high ATP concentrations
[53].
Microglia however did not show DAGL immunoreaction in
OHSC, but in primary microglia culture. Interestingly, DAGL
immunoreacitvity was not observed in microglia after spinal cord
injury [45], although microglia have been shown to produce
important amounts of 2-AG in vitro [54,55].
The distribution of the degrading enzyme MAGL displayed a
surprising pattern. Most studies focused on neuronal expression of
MAGL, however the cellular expression of MAGL during NMDA
lesion and PPT showed a low MAGL expression in astrocytes
compared to controls by immunohistochemistry. It has previously
been reported that astrocytes express the degrading enzyme
MAGL [56,57]. Here, a clear MAGL immunoreaction in
microglia was not found in OHSC but in microglial primary cell
cultures. Recent studies suggest that the ABHD12 enzyme, highly
expressed in microglia accounts for approx. 9% of total brain 2-
Figure 5. Inhibition of MAGL by JZL184 and siRNA exerted
neuroprotective effects. (A) OHSC were treated for 4 h with JZL184
(1 mM) at 6 div. 2-AG levels were significantly elevated in all investigated
(EC, DG, CA1) regions compared to the respective control regions of
untreated OHSC. (B) Decreased neuronal cell death was seen in
excitotoxically lesioned OHSC treated with JZL184 compared to
lesioned OHSC treated with NMDA alone. (C) MAGL knock down by
siRNA reduced the number of degenerating neurons after NMDA-lesion.
(n.3, *=p,0.05, **=p,0.01, ***=p,0.001).
doi:10.1371/journal.pone.0051208.g005
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analogue for microglia as well as in related cell types of peripheral
tissues [59]. The different distribution of DAGL and MAGL
immunoreactivities in different cellular states suggests a highly
defined expression pattern depending on the activation state of the
cells. Therefore, our findings imply a qualitatively different
contribution of 2-AG signaling to distinct lesion models as
described for specific synapses and microcircuits.
CB1 and DAGL are evolutionary closely associated, stating 2-
AG as the endogenous ligand for CB1 [10,60]. Interestingly, we
observed no alteration in the amount of CB1 protein in the DG
24 hpl, the primary target of 2-AG [31]. Recent reports found a
decrease in CB1 by internalization or downregulation after
prolonged 2-AG stimulation in coronal brain section by [
35S]
GTPcS binding [61]. The absence of MAGL led to compensatory
desensitization of the CB1 receptor in the brain as CB1 receptor
density and functional responses were attenuated [61]. Here, we
used JZL184 to induce an up-regulation of intrinsic 2-AG levels
and observed increased 2-AG levels in all investigated regions. It is
reported that chronic inactivation of MAGL by JZL184 dramat-
ically reduced 2-AG break-down, that led to a 10-fold increase of
2-AG levels in the brain as also shown in the present study [58,62].
However, JZL184 was less potent in the CA1 region than in the
DG or the EC, supporting the lower occurrence of MAGL in the
CA1 region.
To further demonstrate that intrinsic up-regulation of 2-AG,
clearly accounts for neuronal protection, we treated NMDA
lesioned OHSC with either JZL184 or MAGL siRNA and
observed decreased neuronal damage in the granular cell layer of
the dentate gyrus under both conditions. Other studies reported
neuroprotective properties of 2-AG in neuronal excitotoxic models
and other cellular settings by using exogenous 2-AG [11,63].
However, in vivo models of closed head injury and focal ischemia
in mice elevated 2-AG levels were found after the lesion [4,64].
The early onset of 2-AG level up-regulation might be provoked by
the blood-brain barrier (BBB) disruption as 2-AG levels were
shown to reduce BBB permeability 1–4 hours after brain injury
[64,65].
In summary, 2-AG is intrinsically involved in general secondary
damage regulation and strongly responds to excitotoxic and
axonal damage in OHSC as a neuroprotective mediator.
Furthermore the DAGL and MAGL dependent regulation of 2-
AG is a dynamic interplay mainly of astrocytes and neurons
embedded in time and cellular organization and involved in
dendritic reorganisation.
Supporting Information
Table S1 Sequences of the used primers.
(TIF)
Figure S1 Specificity test for antibodies against MAGL
by Western blot analyses. (A) The antibody against MAGL
showed two immunoreactive bands of about 35 kDa (1). Both
bands were blocked by use of the respective blocking peptide (2).
(B) MAGL fluorescent staining and MAGL fluorescent staining
after preincubation with the respective peptide for 1 h.
Bar=50 mm.
(TIF)
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